how to treat constipation on tirzepatide Mounjaro (Tirzepatide) & Constipation: The Complete Guide Relief Constipation on GLP-1 Medications: Causes

In the STEP clinical trials, patients on semaglutide 2.4 mg weekly lost an average of 14.9% body weight over 68 weeks

In this double-blind trial of 1,961 adults with a body mass index (BMI) of 30 or higher, adults on high dose 2.4 mg of weekly semaglutide (compared with the usual type 2 diabetes dose of 0.5mg or 1mg) lost an average 14.9% of baseline body weight after 68 weeks of treatment versus only 2.4% for a group on placebo and lifestyle intervention alone

Mounjaro (tirzepatide) is an injectable medicine

Whether you are reconstituting your first vial or fine-tuning an advanced multi-peptide protocol, the tools and guidance you need are all in one place